BenQ Medical Technology Corporation (TPEX:4116)
Taiwan · Delayed Price · Currency is TWD 39.20
-0.10 (-0.25%)
Aug 19, 2026, 1:30 PM CST
BenQ Medical Technology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,445 | 5,254 | 4,767 | 4,543 | 4,377 | 1,465 |
Revenue Growth | 6.83% | 10.21% | 4.94% | 3.80% | 198.82% | 4.55% |
Gross Profit Gross Profit Growth | 1,768 | 1,690 | 1,448 | 1,344 | 1,247 | 512.28 |
Operating Income Operating Income Growth | 340.72 | 342.42 | 333.02 | 365.44 | 350.26 | 46.46 |
Net Income Net Income Growth | 117.69 | 78.17 | 104.83 | 114.58 | 180.24 | 28.84 |
Earnings Per Share EPS Growth | 2.63 | 1.75 | 2.34 | 2.56 | 4.02 | 0.65 |
EPS Growth | 38.12% | -25.21% | -8.59% | -36.32% | 521.20% | -53.44% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Services Medical Services Growth | 4,387 | 3,786 | 3,532 | 3,352 | 481.86 |
R&D and Manufacturing Department R&D and Manufacturing Department Growth | 941.42 | 1,039 | 1,032 | 1,090 | 1,019 |
Adjustment and Elimination Adjustment and Elimination Growth | -74.87 | -56.79 | -20.52 | -65.59 | -35.9 |
Total Total Growth | 5,254 | 4,767 | 4,543 | 4,377 | 1,465 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 821.16 | 1,188 | 1,146 | 1,154 | 1,167 | 419.19 |
Total Debt Total Debt Growth | 2,018 | 1,989 | 1,906 | 1,572 | 1,117 | 491.75 |
Net Cash (Debt) Net Cash Growth | -1,197 | -800.37 | -760.13 | -418.15 | 50.19 | -72.55 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -26.66 | -17.87 | -16.96 | -9.33 | 1.12 | -1.62 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 404.12 | 358.75 | 222.22 | 442.35 | 482.84 | 121.35 |
Capital Expenditures CapEx Growth | -58.26 | -93.91 | -170.09 | -133.47 | -76.89 | -30.26 |
Free Cash Flow Free Cash Flow Growth | 345.86 | 264.84 | 52.14 | 308.88 | 405.95 | 91.09 |
Free Cash Flow Growth | 97.07% | 407.99% | -83.12% | -23.91% | 345.66% | -20.84% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.47% | 32.16% | 30.38% | 29.58% | 28.50% | 34.98% |
Operating Margin | 6.26% | 6.52% | 6.98% | 8.04% | 8.00% | 3.17% |
Pretax Margin | 7.65% | 6.37% | 6.91% | 6.83% | 7.21% | 4.22% |
Profit Margin | 2.16% | 1.49% | 2.20% | 2.52% | 4.12% | 1.97% |
FCF Margin | 6.35% | 5.04% | 1.09% | 6.80% | 9.28% | 6.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 1.650 | 2.000 | 2.100 | 0.500 |
Dividend Per Share Growth | 21.21% | 21.21% | -17.50% | -4.76% | 320.00% | -50.00% |
Dividend Yield | 5.09% | 4.78% | 3.84% | 3.55% | 3.86% | 1.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.97 | 25.14 | 20.07 | 24.89 | 15.82 | 51.30 |
Forward PE | - | 32.83 | 32.83 | 32.83 | 32.83 | 32.83 |
P/FCF Ratio | 5.06 | 7.42 | 40.35 | 9.23 | 7.03 | 16.24 |
PS Ratio | 0.32 | 0.37 | 0.44 | 0.63 | 0.65 | 1.01 |